Genetic Polymorphisms of the CYP19A1 Gene and Breast Cancer Survival

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-06-0464PMID 17119036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF‐α, IL‐6 and COX‐2 mRNAs in human breast cancer

  2006cited by this paper
• Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer.

  2005cited by this paper
• Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

  2005cited by this paper
• Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.

  2005cited by this paper
• Association of genetic polymorphisms in the VEGF gene with breast cancer survival.

  2005cited by this paper
• Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.

  2005cited by this paper
• Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study

  2004cited by this paper
• Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study.

  2004cited by this paper
• Estrogen‐metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women

  2004influential reference
• Organization of the human aromatase p450 (CYP19) gene.

  2004cited by this paper
• Aromatase: Biologic Relevance of Tissue-Specific Expression

  2004cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women

  2003cited by this paper
• A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.

  2003influential reference
• No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.

  2002cited by this paper
• Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals

  2002cited by this paper
• Effect of germ-line genetic variation on breast cancer survival in a population-based study.

  2002cited by this paper
• Aromatase overexpression enhances the stimulatory effects of adrenal androgens on MCF7 breast cancer cells.

  2002cited by this paper
• Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.

  2002cited by this paper
• A new statistical method for haplotype reconstruction from population data.

  2001cited by this paper
• Polymorphic variation in CYP19 and the risk of breast cancer.

  2001cited by this paper
• High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

  2001cited by this paper
• Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study

  2000influential reference
• Breast cancer risk associated with polymorphism in CYP19 in Japanese women

  2000cited by this paper
• A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk

  2000cited by this paper
• Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study.

  1998cited by this paper
• Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.

  1996cited by this paper
• A prospective study of endogenous estrogens and breast cancer in postmenopausal women.

  1995cited by this paper
• Erratum: A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription (Journal of Clinical Endocrinology and Metabolism (1993) 77 (1622-1

  1994cited by this paper
• A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription.

  1993cited by this paper
• A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription [published erratum appears in J Clin Endocrinol Metab 1994 Feb;78(2):494]

  1993cited by this paper
• High plasma concentrations of human atrial natriuretic polypeptide in aged men.

  1987cited by this paper

• PIMO: Pathway-based Interpretable Multi-Omics interactions for multi-omics integration

  2026cites this paper
• Some Novel Synthesis 2-Aroyl-1-acetylhydrazine Derivatives: An Assessment of Their Biological Activity as Therapeutic Agents

  2024cites this paper
• Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer.

  2024cites this paper
• Novel 3-Substituted 8-Methoxycoumarin Derivatives as Anti-Breast Cancer Drugs

  2023cites this paper
• A Novel Attention-Mechanism Based Cox Survival Model by Exploiting Pan-Cancer Empirical Genomic Information

  2022cites this paper
• Association of CYP19A1 Gene, Plasma Zinc, and Urinary Zinc with the Risk of Type 2 Diabetes Mellitus in a Chinese Population

  2022cites this paper
• Network pharmacology-based analysis for unraveling potential cancer-related molecular targets of Egyptian propolis phytoconstituents accompanied with molecular docking and in vitro studies

  2021cites this paper
• The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis

  2021cites this paper
• The CYP19A1 rs700519 Polymorphism and Breast Cancer Susceptibility in China: A Case-Control Study and Updated Meta-Analysis

  2021cites this paper
• MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India

  2020cites this paper
• Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer

  2018cites this paper
• Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial

  2018cites this paper
• Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer.

  2017cites this paper
• Association of CYP19A1 gene polymorphisms with reproductive traits in pigs

  2017cites this paper
• Genetic Polymorphisms in Aromatase (CYP19) Gene and Cancer

  2017cites this paper
• Ancestry as a potential modifier of gene expression in breast tumors from Colombian women

  2017cites this paper
• CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

  2016cites this paper
• Genetic Polymorphisms in Estrogen-Related Genes and the Risk of Breast Cancer among Han Chinese Women

  2015cites this paper
• No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients

  2015cites this paper
• Common germline polymorphisms associated with breast cancer-specific survival

  2015cites this paper
• Resistance to Aromatase Inhibitors in Breast Cancer

  2015cites this paper
• A potentially functional variant in the serotonin transporter gene is associated with premenopausal and perimenopausal hot flashes

  2015cites this paper
• Prediction of Response to Aromatase Inhibitors in Breast Cancer

  2015cites this paper
• Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer

  2014cites this paper
• Influence of low penetrance genes in susceptibility for breast cancer in the portuguese population of Beira Interior

  2014cites this paper
• Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India

  2014cites this paper
• Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study

  2014cites this paper
• Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer.

  2013cites this paper
• Associations between Aromatase CYP19 rs10046 Polymorphism and Breast Cancer Risk: From a Case-Control to a Meta-Analysis of 20,098 Subjects

  2013cites this paper
• A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma

  2013cites this paper
• The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.

  2013cites this paper
• CYP19 Genetic Polymorphism Haplotype AASA Is Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer

  2013cites this paper
• " Aromatase and the Pharmacogenomic Profile - Influence of CYP19A1 polymorphisms in the response of breast cancer patients treated with aromatase inhibitors".

  2012cites this paper
• Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients

  2012cites this paper
• Positive Association of Polymorphisms in Estrogen Biosynthesis Gene, CYP19A1, and Metabolism, GST, in Breast Cancer Susceptibility

  2012cites this paper
• Pharmacogenetics of aromatase inhibitors.

  2012cites this paper
• A study of matrix metalloproteinases in cancer and atherosclerosis.

  2012cites this paper
• A non-synonymous coding change in the CYP19A1 gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture

  2011cites this paper
• Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer

  2011cites this paper
• A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole

  2010influential citation
• Pharmacogenetics of Aromatase Inhibitors: Present Understanding and Looking to the Future

  2010cites this paper
• Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men.

  2010cites this paper
• Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women

  2009cites this paper
• Role of genetic polymorphisms and ovarian cancer susceptibility

  2009cites this paper
• NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.

  2009cites this paper
• Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer

  2009cites this paper
• Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients

  2008influential citation
• Pharmakogenetik in der antihormonellen Therapie von Patientinnen mit einem Mammakarzinom

  2008cites this paper
• Genetic Variation in CYP19A1 and Risk of Breast Cancer and Fibrocystic Breast Conditions among Women in Shanghai, China

  2008cites this paper
• The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.

  2008cites this paper
• A Rapid Outcomes Ascertainment System Improves the Quality of Prognostic and Pharmacogenetic Outcomes from Observational Studies

  2008cites this paper
• Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women

  2008cites this paper
• Association of Mitochondrial DNA Displacement Loop (CA)n Dinucleotide Repeat Polymorphism with Breast Cancer Risk and Survival among Chinese Women

  2008cites this paper
• Pharmakogenetik in der antihormonellen Therapie von Patientinnen mit einem Mammakarzinom

  2008cites this paper
• Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.

  2007influential citation
• Genes in Estrogen Metabolism Pathway and Breast Cancer

  2007cites this paper